Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor-
dc.contributor.advisorKesmir, Can
dc.contributor.authorPullens, Shane
dc.date.accessioned2023-02-09T01:00:52Z
dc.date.available2023-02-09T01:00:52Z
dc.date.issued2023
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/43519
dc.description.abstractNeo-antigens are a promising area of research in the development of immunotherapies against cancer. The neo-antigens arise due to mutations in cancerous cell, which often helps the cancer cell to hide from the surveillance of the immune system. In the last decade, the amount of mass spectrometry data has been growing exponentially. Researchers often found that the origin of all peptides eluted from cancer cells could not be mapped, which suggest that the tumor alters the translation process to generate new peptides that are presented in the MHC-complex on the cell surface. Obviously, this finding opens up a totally new area for cancer specific biomarkers. Here we present our pipeline to identify these non-canonical (cryptic) peptide candidates from RNA count data.
dc.description.sponsorshipUtrecht University
dc.language.isoEN
dc.subjectFor this thesis, I explored the possibilities to develop an automated pipeline that detects represented non-canonical, neo-antigens (cryptic peptides) on the surface of tumor cells.
dc.titleAutomating biomarker identification for immunotherapies: Non-canonical peptides presented on MHC molecules
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.keywordsCryptic, peptides, MHC, netMHCpan, Cancer, Oncology, pipeline, data analysis
dc.subject.courseuuBioinformatics and Biocomplexity
dc.thesis.id13646


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record